Research Article

Whole Blood Stimulation Assay as a Treatment Outcome Monitoring Tool for VL Patients in Ethiopia: A Pilot Evaluation

Table 1

Sociodemographic and clinical characteristics of study participants in Gondar, Ethiopia.

VariablesVL patients ()

Demographic characteristics
 Male gender, (%)13 (100)
 Age (years), median (min–max)22 (17-27)
 Occupation, (%)
  Farmer6 (46.1)
  Daily labourer7 (53.9)
 Literacy, (%)5 (38.4)
 Marital status, (%)
  Single12 (92.3)
  Married1 (7.7)
 Migrant worker, (%)12 (92.3)
Clinical characteristics
 BMI, median (kg/m2) (min–max)16.4 (13.6-18.4)
 Fever, (%)9 (69.2)
 Conjunctival pallor, (%)12 (92.3)
 Edema, (%)6 (46.2)
 Other pathology, (%)3 (23.1)
 Palpable spleen size (cm),
 Parasite load (parasites/field), median (min–max)3 (1-6)
 Type of treatment, (%)PM+SSG10 (76.9)
AmBisome3 (38.5)
 Treatment duration (days), median (min–max)PM+SSG17 (15-20)
AmBisome19 (14-22)

min: minimum; max: maximum; : total number; SD: standard deviation; PM: paromomycin; SSG: sodium stibogluconate.